Management Team
Board of Directors
Grants
LUVOX CR
LUVOX
Xyrem
Antizol
Product Reimbursement Assistance
News
Meetings
Overview
Corporate Governance
Stock Information
News Releases
SEC Filings
Investor FAQs
E-mail Alerts
Information Request
Driving Directions
07/16/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES $26.0 MILLION REGISTERED DIRECT OFFERING
06/11/2008 | Press Release
JAZZ PHARMACEUTICALS FILES FORM S-3 REGISTRATION STATEMENTS
06/11/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES DEVELOPMENT TIMELINE UPDATES
06/02/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. COMPLETES ENROLLMENT IN FIRST OF TWO PHASE III CLINICAL TRIALS OF SODIUM OXYBATE TO TREAT FIBROMYALGIA
05/13/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS
05/09/2008 | Press Release
JAZZ PHARMACEUTICALS TO PRESENT AT CITIGROUP HEALTHCARE FORUM
05/08/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. SECURES $75 MILLION COMMITTED EQUITY FINANCING FACILITY
05/07/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. TO ANNOUNCE FIRST QUARTER RESULTS ON MAY 13, 2008
04/23/2008 | Press Release
JAZZ PHARMACEUTICALS TO PRESENT AT MORGAN STANLEY CONFERENCE
04/14/2008 | Press Release
JAZZ PHARMACEUTICALS' LUVOX CR IS NOW AVAILABLE FOR PATIENTS WITH SOCIAL ANXIETY DISORDER (SAD) AND OBSESSIVE COMPULSIVE DISORDER (OCD)
Take a look at the current career opportunities available at Jazz Pharmaceuticals and apply online.
Apply
Site Map
Homepage
About Us
Management Team
Board of Directors
Our Products
LUVOX CR
Xyrem
Antizol
LUVOX
Product Reimbursement Assistance
News & Meetings
News
Meetings
Media Kit
Partnering
Careers
Contact Us
Driving Directions
Privacy Policy & Terms of Use
Site Map
© 2008 Jazz Pharmaceuticals, Inc. :
Privacy Policy & Terms of Use
About Us
:
Our Products
:
News & Meetings
:
Partnering
:
Investors
:
Careers
:
Contact Us
:
Site Map
:
Product Reimbursement Assistance
